Welcome to our dedicated page for Piper Sandler Co`S news (Ticker: PIPR), a resource for investors and traders seeking the latest updates and insights on Piper Sandler Co`S stock.
Piper Sandler Companies (NYSE: PIPR), the Minneapolis-based investment bank founded in 1895, maintains this dedicated news hub for tracking financial developments across its core sectors including healthcare, technology, and energy markets. Investors and analysts will find timely updates on mergers & acquisitions, capital raising activities, and strategic partnerships.
This resource consolidates all essential PIPR updates including earnings announcements, leadership changes, and regulatory filings. Users gain direct access to primary source documents alongside analysis of market-moving developments in middle-market advisory services and debt financing operations.
The archive features categorized updates on PIPR's investment banking activities, public finance initiatives, and cross-border transactions. Regular updates cover sector-specific developments in healthcare M&A, technology IPOs, and energy sector restructuring – all critical areas of the firm's expertise.
Bookmark this page for streamlined tracking of PIPR's financial performance, strategic alliances like the BC Partners Credit collaboration, and regulatory updates affecting its global operations. Check back regularly for verified updates from one of America's oldest continuously operating investment banks.
Piper Sandler Companies (NYSE: PIPR) has scheduled the release of its first quarter 2025 financial results before market opening on Friday, May 2, 2025. The company will host a conference call at 8 a.m. ET (7 a.m. CT) on the same day to discuss the results.
Key executives participating in the call include Chairman and CEO Chad Abraham, President Deb Schoneman, and CFO Kate Clune. The earnings release will be accessible at pipersandler.com/earnings. Investors and analysts can join the live conference call by dialing 888 394-8218 (U.S.) or +1 773 305-6853 (international) with passcode 9183623.
Piper Sandler (NYSE: PIPR) has released its 49th semi-annual Taking Stock With Teens® survey for spring 2025, analyzing preferences and spending habits of over 6,450 Generation Z U.S. teens. The survey reveals teen annual spending reached $2,388, showing an increase from both spring and fall 2024.
Key findings include:
- Fashion & Shopping: Nike remains the top clothing brand, followed by Hollister and American Eagle. UGG has become the #1 fashion trend among upper-income females, replacing lululemon. Amazon leads as the top shopping website.
- Beauty: Core beauty wallet hits record high at $374. e.l.f. Cosmetics leads cosmetics brands, while Sephora, Ulta, and Bath & Body Works top beauty shopping destinations.
- Technology: Instagram (87% usage), TikTok (79%), and Snapchat (72%) are top social platforms. 88% of teens own iPhones, with 25% planning iPhone 17 upgrades.
- Food & Beverages: Chick-fil-A leads restaurant preferences, followed by McDonald's and Chipotle. Energy drinks surpass coffee and soda, with Dr. Pepper as the top beverage brand.
Piper Sandler Companies (NYSE: PIPR) has announced the appointment of Christian Draisbach as managing director to their healthcare investment banking team. Draisbach, who joins from Centerview Partners, brings 20 years of experience in advising biopharma executives and boards on strategic initiatives, mergers, acquisitions, divestitures, and partnership transactions across the U.S., Europe, and Asia.
Previously at Morgan Stanley in mergers and acquisitions and financial sponsor coverage groups, Draisbach holds an M.Sc. in finance from the London School of Economics and a B.A. from the University of St. Gallen. He will focus on advising and supporting clients in the biopharma sector, leveraging his experience that spans from early development-stage private transactions to major public deals.
Piper Sandler (NYSE: PIPR) has announced the opening of a new office in Zurich, Switzerland, expanding its research distribution capabilities. The office will be led by three industry veterans from Credit Suisse: Alex Molloy, Vincenzo Pescuma, and Luigi Colazzo, who will manage sales and distribution of U.S. equity research and trading products to Swiss clients.
The company's equity research platform ranks among the top 10 investment banks globally for U.S. equities coverage. Notably, Piper Sandler was voted #1 small and mid-cap liquidity provider in the 2024 Extel U.S. Equity Trading Study. The firm is also planning to open a new office in Paris, France, as part of its European expansion strategy.
The expansion includes the hiring of six sales and trading professionals, all formerly from Credit Suisse, across Zurich, Paris, London, and New York offices.
Piper Sandler (NYSE: PIPR) has announced the appointment of Mary Stone as managing director and co-head of the structured finance group, working alongside Chris Howley in the New York office. Stone brings extensive experience in securitization markets, whole loan trading, and deal structuring from her previous roles as managing director and head of structured credit banking at StoneX Group Inc., and head of residential mortgage securitization and advisory at Bank of America.
Piper Sandler (NYSE: PIPR) has expanded its private capital advisory investment banking group with three key appointments. Ahsan Khan joins as managing director, while Jonathan Hartland and Andrew Fair join as directors, strengthening the firm's GP advisory and distribution capabilities across the Middle East, Europe, and North America.
Khan, previously director at Asante Capital Group, brings over 12 years of financial services experience. Hartland, with more than a decade of GP advisory experience, joins from Rede Partners LLP. Fair, joining the New York office, previously served as director at Connaught and co-led their North American office.
The expansion particularly focuses on strengthening EMEA operations, identified as a key strategic priority, to execute complex fundraising mandates and provide market intelligence. The team aims to enhance client services with data-driven insights and strategic guidance for fund managers.
Piper Sandler Companies (NYSE: PIPR) has announced a new share repurchase program authorized by its board of directors. The program allows for the repurchase of up to $150 million of the company's outstanding common stock, effective immediately and extending through December 31, 2026.
The initiative is part of the company's capital allocation strategy, serving two main purposes: returning capital to shareholders and offsetting dilution from employee equity-based compensation. This new authorization replaces the previous share repurchase program that was set to expire on December 31, 2024.
Piper Sandler Companies (NYSE: PIPR) has announced the release of its Q4 and full-year 2024 financial results. The company has declared a special dividend of $3.00 per share and a quarterly dividend of $0.65 per share. The complete earnings release is available on the company's website. An earnings conference call is scheduled for January 31, 2025, at 8:00 a.m. CT, with dial-in options available for both U.S. and international participants.
Piper Sandler Companies (NYSE: PIPR) announced it will release its fourth quarter and full year 2024 financial results before market opening on Friday, January 31, 2025. The company will host a conference call at 9 a.m. ET (8 a.m. CT) on the same day to discuss the results.
Chairman and CEO Chad Abraham, President Deb Schoneman, and CFO Kate Clune will lead the conference call, which will include a Q&A session. Investors and analysts can participate by dialing 888 394-8218 (U.S.) or +1 773 305-6853 (international) with passcode 7788151. The earnings release and audio webcast will be available at pipersandler.com/earnings, with a replay accessible afterward through the same link.
Piper Sandler Companies (NYSE: PIPR) has announced the appointment of John Kerins as managing director to their healthcare investment banking team. Based in New York, Kerins will focus on the pharma services sector. He brings 10 years of experience from Cain Brothers & Company, where he served as managing director in healthcare M&A, and six years at Deloitte in M&A advisory services.
J.P. Peltier, global group head of healthcare investment banking at Piper Sandler, highlighted Kerins' transaction experience and strong relationships with healthcare private equity funds as complementary assets to their practice. The appointment aligns with the firm's focus on pharma services, which they identify as a rapidly growing market segment.
Kerins holds a bachelor's degree from Kenyon College and an MBA from Fordham University Gabelli School of Business.
